PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,412 Cr | ₹1,443 Cr | ₹1,735 Cr | ₹1,177 Cr | ₹1,559 Cr |
What is the latest Total Liabilities ratio of PANACEA BIOTEC ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹1,412 Cr |
| Mar2023 | ₹1,443 Cr |
| Mar2022 | ₹1,735 Cr |
| Mar2021 | ₹1,177 Cr |
| Mar2020 | ₹1,559 Cr |
How is Total Liabilities of PANACEA BIOTEC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,412 Cr | -2.11 | |
| Mar2023 | ₹1,443 Cr | -16.86 | |
| Mar2022 | ₹1,735 Cr | 47.37 | |
| Mar2021 | ₹1,177 Cr | -24.46 | |
| Mar2020 | ₹1,559 Cr | - | |
Compare Total Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,494.0 Cr | -11.6% | -0.2% | 23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,631.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
| CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -11.6% |
-0.2% |
23.7% |
| SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses